Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Cancer Chemotherapy and Pharmacology|October 3, 2013
Phase II, open-label trial to assess QTcF effects, pharmacokinetics and antitumor activity of afatinib in patients with relapsed or refractory solid tumorsL Rhoda Molife, Sarah M Rudman, Salma Alam, et al.
Gut|August 20, 2018
Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinomaDeepak Raj, Ming-Hsin Yang, David Rodgers, et al.
Molecular Cancer|January 5, 2013
Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletionNeel Sengupta, Christopher Yau, Anuratha Sakthianandeswaren, et al.
Human Molecular Genetics|February 17, 2017
Remodelling of microRNAs in colorectal cancer by hypoxia alters metabolism profiles and 5-fluorouracil resistanceAnke Nijhuis, Hannah Thompson, Julie Adam, et al.
British Journal of Cancer|February 14, 2018
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinomaNatalie Cook, Bristi Basu, Donna-Michelle Smith, et al.
Redox Biology|November 6, 2025
Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancerGayle S Jameson, S Danielle LeGrand, Michael S Gordon, et al.
The Lancet. Oncology|June 7, 2011
Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trialRichard A Adams, Angela M Meade, Matthew T Seymour, et al.
Nature Communications|August 18, 2018
The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent mannerMette Ø Agerbæk, Sara R Bang-Christensen, Ming-Hsin Yang, et al.
The Lancet. Oncology|March 6, 2017
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trialGary Middleton, Daniel H Palmer, William Greenhalf, et al.
Cancer Discovery|June 30, 2022
A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1βIrene Olivera, Rebeca Sanz-Pamplona, Elixabet Bolaños, et al.
Pageof 3